Furthermore, combining spatiotemporal transcriptomics with protein–protein interaction networks revealed that fibronectin-1 and protease inhibitor alpha-2-macroglobulin are associated with CAVD progression56. Here, A2M is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.